Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Sports Medicine Market to Hit USD 9.45 Billion by 2029 with 6.8% CAGR |…
Browse in-depth TOC on "Sports Medicine Market" Browse in-depth TOC on "Sports Medicine Market" 245 - Tables37 - Figures280 - Pages Drivers of Growth The sports medicine market is primarily driven by the rising demand for body reconstruction products, which accounted for the largest share of the market. High-impact activities and physical contact in sports often lead to fractures and ligament injuries, creating a growing need for effective recovery solutions...
PR Newswire
18/09/2024
Live Cell Imaging Market Surges to USD 4.42 Billion by 2030, Propelled by 7.52%…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=847280 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=847280 Browse in-depth TOC onLive Cell Imaging Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Live Cell Imaging Market Overview Market Drivers Fueling Growth in the Live Cell Imaging Market Advancements in Imaging Technologies Recent innovations in imaging...
PR Newswire
18/09/2024
OM1 Earns Frost & Sullivan's 2024 North American New Product Innovation Award…
OM1's innovative approach integrates multiple data sources into a cohesive, actionable dataset that enhances clinical decision-making and research effectiveness. The company's solutions, such as OM1 Orion, OM1 Lyra, and OM1 Polaris, offer precise patient journey analysis, personalized real-time insights, and optimized clinical trial recruitment. By utilizing artificial intelligence (AI), these cutting-edge platforms process extensive clinical data that enables healthcare professionals to uncover…
PR Newswire
18/09/2024
Business update - opdatering på identitetsændring:
Selskabet annoncerede i selskabsmeddelelse 13/2024, at man havde indledt en proces med at gennemføre et identitetsskifte med Nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab.Nasdaq har dags dato meddelt selskabet, at man har modtaget en betinget godkendelse herom, men at den fortsatte børsnotering er betinget af, at man opdaterer selskabets risikobeskrivelse iht. selskabets fremadrettede formål, hvor man udover strategiske partnerskaber indenfor biotek også ønsker at...
Nasdaq GlobeNewswire
18/09/2024
Notice of Annual General Meeting 2024
ANNOUNCEMENT NO. 275 18 September 2024 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 10 October 2024 at 5.30 p.m.The general meeting will be held at Nordsjællands KonferenceCenter, Gydevang 39-41, 3450 Allerød. Additional Info Kim Nicolajsen, CFO Telephone: (+45) 48 13 10 20 About ChemoMetec A/SChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of...
Nasdaq GlobeNewswire
18/09/2024
Ketabon To Present Advancements In At-Home Ketamine Therapy For…
Presentations Will Highlight Oral Prolonged-Release Ketamine (KET01) And its Minimal Impact on Sleep, Alongside Excellent Day-One Tolerability in Patients 37th European College of Neuropsychopharmacology (ECNP) Congress 2024 , taking place on September 21-24, 2024 in Milan. KET01 is an oral prolonged-release ketamine formulation developed for treatment-resistant depression (TRD). Topline results from the Phase 2 trial, published in August 2023 , demonstrated rapid improvement in...
Nasdaq GlobeNewswire
18/09/2024
Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving…
New Biological Data Released from IRO® Cell Therapy Manufacturing Platform ® ( ee-RO ). In early 2024, Ori and Charles River collaborated through Ori's LightSpeed Early Access Program (LEAP), designed to provide access to the IRO platform for use in clinically relevant applications. During the collaboration, Ori and Charles River conducted head-to-head process runs comparing the IRO platform's biological performance to a process Charles River specifically optimized for CAR-T therapy over...
Nasdaq GlobeNewswire
18/09/2024
Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for…
Our preliminary tabulation indicates the voting threshold has not been reached on Proposals 3 & 5. The proposed Merger cannot proceed unless holders of a majority of the voting power of Kintara's outstanding shares as of August 14, 2024 are voted FOR Proposals 3 & 5 (as described below). Our preliminary tabulation indicates the voting threshold has not been reached on Proposals 3 & 5. The proposed Merger cannot proceed unless holders of a majority of the voting power of Kintara's...
PR Newswire
18/09/2024
Venturi Cardiology and Caristo Diagnostics Introduce AI-Enabled Heart Disease…
OXFORD, England, Sept. 18, 2024 /PRNewswire/ -- Venturi Cardiology, a leading, state of the art cardiology clinic in North West England offering rapid access to clinical consultations and advanced diagnostics, has partnered with Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, to offer Caristo's AI-enabled CaRi-Heart® technology to patients in its growing practice. Venturi Cardiology is part of DHC Group, a portfolio of healthcare companies that…
PR Newswire
18/09/2024
Tilray Medical Launches Redecan Cannabis Brand in Australia
EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical Prescription Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, “The launch of Redecan, a premium cannabis brand, in Australia is another significant milestone for Tilray Medical, as we relentlessly pursue our vision of making high-quality medical cannabis products accessible to patients worldwide. The launch of Redecan further expands our medical cannabis portfolios alongside...
Nasdaq GlobeNewswire
18/09/2024
Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered…
Abstract Title Abstract Title Safety and efficacy of a novel CAR-T cell therapy (BRG01) targeting the Epstein-Barr Virus envelope glycoprotein in advanced metastatic nasopharyngeal cancer (NPC) patients Abstract No.: 899P The presentation highlights that the Phase I clinical trial of BRG01 has successfully completed dose-limiting toxicity (DLT) observations and efficacy evaluations in nine patients,all diagnosed with advanced NPC. Notably, 100% of participants had previously...
PR Newswire
18/09/2024
Thermo Compression Forming Market worth $13.37 billion by 2029 - Exclusive…
240 – Tables 59 – Figures 260 – Pages 240 – Tables59 – Figures260 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114021695 Thermoplastic Foams by type segment dominate the market by highest share of the thermo compression forming market during the forecasted period. Thermoplastic Foams are dominating because of their balanced mechanical qualities and excellent performance-to-cost ratios. These foams have many beneficial...
PR Newswire
18/09/2024
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at…
Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks' proprietary antibody-drug conjugate development platforms "We are excited to share results from our preclinical studies, which highlight the activity of ZW220 in models of non-small cell lung, ovarian, and uterine cancers, as well as ZW251 in hepatocellular carcinoma models, both of which leverage our novel proprietary payload, ZD06519," said Paul Moore, Ph.D., Chief Scientific…
Nasdaq GlobeNewswire
18/09/2024
Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of…
The advance purchase agreement (APA) will be funded by Gavi's First Response Fund, a mechanism created after the COVID-19 pandemic to ensure rapid access to scarce vaccine supplies in future health emergencies.Availability of all 500,000 doses has been secured for 2024.COPENHAGEN, Denmark and GENEVA, Switzerland, September 18, 2024– Bavarian Nordic A/S (OMX: BAVA) and Gavi, the Vaccine Alliance today announced an advance purchase agreement (APA) to secure 500,000 doses of the MVA-BN ®...
Nasdaq GlobeNewswire
18/09/2024
TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of…
Founded by Dr. J. Craig Venter, one of the pioneers of the human genome sequencing effort, HLI builds on his vision for a longer, healthier life and the democratization of genomics to revolutionize the way we evade "avoidable disease" and stay healthy longer. The company is recognized as a leader in the rapidly expanding industry of longevity medicine due to its deep expertise in genomics and other fields of precision medicine such as imaging, and its unmatched, longitudinal patient…
PR Newswire
18/09/2024
Tetra Pharm Technologies Relocates to Copenhagen Towers
"Driven by our vision for innovation, we've chosen Copenhagen Towers as our new home. Its vibrant business ecosystem and exceptional amenities align perfectly with our mission", says Jesper Breum, COO, Tetra Pharm Technologies. "Driven by our vision for innovation, we've chosen Copenhagen Towers as our new home. Its vibrant business ecosystem and exceptional amenities align perfectly with our mission", saysJesper Breum, COO, Tetra Pharm Technologies. Copenhagen Towers…
PR Newswire
18/09/2024
Kitchen Sinks Market to Reach $5.4 Billion, Globally, by 2034 at 3.9% CAGR…
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A16899 Request The Sample PDF Of This Report:https://www.alliedmarketresearch.com/request-sample/A16899 Prime determinants of growth Increase in home renovation and remodeling activities, driven by consumer desire for modern and functional kitchen spaces, have boosted demand for innovative kitchen sink designs. The trend toward open and aesthetically pleasing kitchen layouts has led to...
PR Newswire
18/09/2024
Biocomposites acquires remaining shares in manufacturers of SYNICEMTM and…
KEELE, England, Sept. 18, 2024 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce the acquisition of the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. – gaining full control of the SYNICEMTM and Subiton product ranges. KEELE,England,Sept. 18, 2024/PRNewswire/ --Biocomposites, an...
PR Newswire
18/09/2024
Clarivate Announces 15th Annual Pharmavision India Conference Agenda
In a country with billions of people, addressing challenges such as healthcare affordability and access is crucial. Organizations must adopt effective, patient-centric approaches across diverse functions to ensure return on investment and a competitive advantage. As the healthcare landscape evolves, balancing these priorities is essential for sustainable growth and better patient outcomes. Pharmavision India 2024 will provide attendees with the opportunity to tackle the industry's most urgent…
PR Newswire
18/09/2024
Implantica announces excellent data from an independent study of 158 RefluxStop™…
This German study included 158 patients and reported impressive two-year follow-up effectiveness and safety outcomes with patients achieving significant improvement in their symptoms, and as a result, 96.4% of patients discontinued their regular PPI medication. An impressive 90.9% improvement in GERD-HRQL quality of life score was achieved although many of the patients had difficult-to-treat conditions, such as 22% had large hiatal hernia (over 3 cm), 44% active esophagitis and 10% precancerous…
PR Newswire
18/09/2024
Medvarsity Announces the AI Revolution in Healthcare Summit: The Largest AI in…
Gerald Jaideep, CEO of Medvarsity, emphasized the importance of the event, adding that, "AI is reshaping healthcare, from diagnostics to drug discovery. This event represents our commitment to bringing together visionary thinkers to explore the potential of AI in healthcare. Together, we can challenge existing approaches and reshape the future of patient care. AIRH Summit provides an opportunity for innovators to connect, exchange ideas, and drive change." Gerald Jaideep, CEO of…
PR Newswire
18/09/2024
One of Europe's largest port-infrastructure companies implements Aino Health's…
One of Europe's largest port-infrastructure companies implements Aino Health's SaaS-solution for 850 employees, to be socially sustainable and to strengthen their position as a productive, attractive and future-proof employer. One of Europe's largest port-infrastructure companies has chosen to implement Aino Health's SaaS-solution Health Manager. The agreement includes a total of 850 new subscriptions. The implementation of Aino has been initiated from the ambition to digitize all work...
Nasdaq GlobeNewswire
18/09/2024
Nicox Announces Approval of ZERVIATE in China
Press ReleaseNicox Announces Approval of ZERVIATE in China Nicox's partner, Ocumension Therapeutics, has received approval for ZERVIATE ®for ocular itching in China ZERVIATE ®launch in China will add a further royalty revenue stream for NicoxSeptember 18, 2024 – release at 7:30 am CETSophia Antipolis, France Nicox SA(Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that its exclusive Chinese...
Nasdaq GlobeNewswire
18/09/2024
Valneva Submits Label Extension Applications for its Chikungunya Vaccine…
To potentially include adolescents and antibody persistence up to two yearsSaint Herblain (France), September 18, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to potentially expand the use of its chikungunya vaccine, IXCHIQ ®, to adolescents aged 12 to 17 years in Europe and Canada. The Canadian label extension application...
Nasdaq GlobeNewswire
18/09/2024
Altri Comunicati
